This is an opportunity for an Analytical Scientist to join a company who are committed to harnessing the unique properties of their T Cell technology to revolutionise the world of immunotherapies. This is an influential role where you will be contributing to, and influencing, the design of experimental programmes for the charcterisation of T Cell therapies.
As an Analytical Development Scientist, you will contribute to and influence the design of experimental programmes and then manage programmes in the laboratories. With the purpose to develop analytical methods and assays to support pre-clinical R&D and the manufacture of their cell therapy pipeline.
You will lead the design of experimental programmes to address a specific challenge in alignment with agreed project aims.
Line management of Associate Scientists and / or Technicians
Develop & validate methods for multi colour flow cytometry.
Develop & validate methods for immunoassays, cell-based assays, and PCR.
Manage the data sets, trend & analyse these to direct research and for use in presentations.
Transfer of methods to QC or Manufacturing environments for example.
Ensure work is completed to the company’s high standards and regulatory compliance.
Mentor and support the development of more junior colleagues
Required Skills & Expertise:
You will need:
A PhD or MSc and subsequent experience in the Cell Therapy, ATMP, or Biologics sectors for example
Experience of multi colour flow cytometry
Experience of Immuno assays, cell-based assays, and PCR (preferably ddPCR)
Experience in the characterisation of T Cell therapies or Immunotherapies
Experience in the design of experimental programmes, project leadership or supervisory experience.
The company are a leading T Cell Therapy company who have developed a specific technology to harness their unique properties that is set to revolutionise the world of immunotherapies and the lives of patients. Their mission is to deliver allogenic using unique properties of specific T cells that provide additional benefits to the survival of patients suffering from cancer. These cells are more effective because they do not target healthy tissues but eradicate infectious or cancerous cells by triggering a response through the adaptive immune system. They now have therapies at pre clinical stages which are set to progress to clinical trials plus focusing on the development of new immunotherapies as they explore the potential of their technology.
As a company they have offer excellent career progression opportunities with a strong learning & development focus and roles where you gain exposure to develop your career. With a collaborative environment where they are committed to the delivery of life changing cancer therapies to improve patient’s lives.